Treace Medical Concepts Inc (NAS:TMCI)
$ 7.9 -0.02 (-0.25%) Market Cap: 493.39 Mil Enterprise Value: 481.34 Mil PE Ratio: 0 PB Ratio: 4.69 GF Score: 51/100

Q2 2024 Treace Medical Concepts Inc Earnings Call Transcript

Aug 06, 2024 / 08:30PM GMT
Release Date Price: $6.66 (+5.21%)
Operator

Good day, and thank you for standing by. Welcome to the Treace Medical Concepts second-quarter 2024 earnings conference call. (Operator Instruction) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Vivian Cervantes, Gilmartin, Investor Relations. Please go ahead.

Vivian Cervantes
Treace Medical Concepts Inc - Investor Relations

Good afternoon, everyone, and welcome to our second-quarter 2024 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, Chief Financial Officer. During the call, John will offer commentary on our commercial activities, followed by Mark for a detailed review of our second-quarter financial results released after market closed today.

We will host a question-and-answer session following our prepared remarks. Our press release can be found in the Investor Relations section of our website at investors.treace.com. This call is being recorded and will be archived in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot